Document:

Letter Agreement, dated March 11, 2005 between Avecia Limited and Corgentech Inc

 EXHIBIT 10.41 
  
 [ * ] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN
THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY
WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 24B-2 OF
THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. 
  
 March 11, 2005 
  
 Malcolm Stewart 
 Vice President, DNA Medicines 
 Avecia Limited 
 Hexagon House, Blackley 
 Manchester M9 8ZS 
 England 
  

			
	Re:	 	Agreement between Corgentech Inc. and Avecia Limited, Dated December 27, 2004

  
 Dear Malcolm: 
  
 This letter will amend the Agreement dated December 27, 2004 between Corgentech Inc.
(“Corgentech”) and Avecia Limited (“Avecia”) as previously amended by the letter from Jack X. Regan to Kevin Cox dated March 4, 2005 (as amended, the “Agreement”). Except as expressly set forth in this letter, all other
terms of the Agreement shall remain unmodified and in full force and effect. 
  
 I. Amending Section 2.4. 
  
 Section 2.4 of the Agreement is
hereby amended by striking the section and replacing it with the following: 
  
 Upon completion of the Programme, but in no event later than April 30, 2005, Corgentech shall notify Avecia of its intention to continue future manufacturing and production of the Products at Avecia’s Grangemouth
facility (“Grangemouth”). In the event Corgentech notifies Avecia that Corgentech intends to continue future manufacturing and production at Avecia’s Grangemouth facility the parties shall negotiate in good faith an agreement
governing such production within [ * ] after such notification. In the event Corgentech notifies Avecia that it does not intend to continue production at Grangemouth, Avecia shall cooperate fully in the documentation of all manufacturing and
production processes related to the Programme and the manufacture of the Products, including the Technical Information (as defined below) (“the Technology Transfer Documentation”) and communication and delivery to Corgentech of the
Technology Transfer Documentation. As part of the Technology Transfer, Avecia: (a) will deliver all equipment and assets belonging to Corgentech to Corgentech’s facility or as it may direct, and (b) hereby grants to Corgentech a royalty-free,
irrevocable, perpetual, non-exclusive, world-wide license, with power to sub-license, under all New Intellectual Property owned by Avecia pursuant to Section 5.3 below to make, use, sell, offer for sale, import, keep and otherwise deal in the
Products. “Technical Information” shall include, but not be limited to, all know-how, experience, instructions, standards, methods, test and trial results, manufacturing processes, hazard assessments, registration data, quality control
standards, formulae, Specifications, storage data, samples, drawings, designs, descriptions of packaging materials and all other relevant information relating to the Products or the design, manufacture or storage of the Products. In consideration
for the technical consultancy services relating to the Technology Transfer to Corgentech, Corgentech shall pay Avecia’s reasonable costs of producing the documentation and transferring the assets associated with the Business from the
Grangemouth facility to Corgentech (or as it shall direct), for an agreed period, not to exceed [ * ] . Avecia and Corgentech shall each use their reasonable efforts to determine the cost of the Technology Transfer before [ * ] .

  
 II. Amending Section 3.1. 

 
 Section 3.1 is hereby amended by striking the first paragraph thereof and accompanying
table and replacing them with the following: 
  
 In consideration
of Avecia: (i) manufacturing, selling and delivering the Products and undertaking related activities, as more particularly described in the Programme set forth in Part B of Schedule 1; and (ii) continuing production at its Grangemouth facility,
Corgentech shall [ * ] the purchase price for the Products, in four (4) installments. Installments 1, 2, 3 and 4 shall be as set forth in the following table. These amounts do not include [ * ] , which shall be [ * ] . 

 [ * ] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED
IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED AND FILED
SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 24B-2
OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. 
  
 Purchase Price 
  

							
	 Installment

	  	 Amount
 (U.S.$)

	 	Activity

	 	Payment Date

	 1
	  	[ * ]	 	Programme commencement and
[ * ] as set forth in Schedule 1	 	[ * ]
				
	 2
	  	[ * ]	 	[ * ] as set forth in Schedule 1	 	[ * ]
				
	 3
	  	[ * ]	 	[ * ] as set forth in Schedule 1	 	[ * ]
				
	 4
	  	[ * ]	 	[ * ] as set forth in Schedule 1	 	[ * ]

  
 III.
Amending Schedule 1. 
  
 Schedule 1 is hereby amended by adding the April
production schedule attached to this letter. 
  
 Corgentech Inc. 
  

			
	By:	 	 /s/ Jack X. Regan

	 	 	Jack X. Regan
	 	 	Vice President, Manufacturing

  
 Accepted and agreed, 
 Avecia Limited 
  

			
	By:	 	 /s/ Malcom J. Stewart

	Name:	 	Malcom J. Stewart
	Title:	 	Vice President DNA Medicines

 [ * ] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED
IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED AND FILED
SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 24B-2
OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. 
  
 [ * ]Consent and waiver No. 1 to Credit Agreement

 Exhibit 10.1 
  
 CONSENT AND WAIVER NO. 1 
 TO CREDIT AGREEMENT 
  
 This CONSENT AND WAIVER NO. 1 TO CREDIT AGREEMENT (this “Consent and Waiver”), dated as of April 4, 2005, is made among Sabine Pass LNG, L.P., a Delaware limited partnership (the “Borrower”),
Société Générale, in its capacity as administrative agent for the Lenders (the “Agent”) and HSBC Bank USA, National Association, in its capacity as collateral agent for the Lenders (the
“Collateral Agent”). 
  
 W I
T N E S S E T H 
  
 WHEREAS, the Borrower, the Agent and the Collateral Agent are party to a Credit Agreement dated as of February 25, 2005 (as amended, modified and supplemented and in effect from time to time, the “Credit Agreement”),
pursuant to which the lenders from time to time party thereto (the “Lenders”) have agreed to make loans to the Borrower in an aggregate principal amount of $822,000,000; 
  
 WHEREAS, the Borrower has requested that the provisions of the EPC Contract and the Credit Agreement requiring the Borrower
and the EPC Contractor to procure certain insurance coverage no later than the Notice to Proceed be amended to permit such coverage to be procured within 60 days of the date on which the Borrower issues the Notice to Proceed; 
  
 WHEREAS, the Borrower desires to conduct certain preliminary planning work in
connection with a potential expansion of the Project as more fully described in the waiver request letter (the “Waiver Request Letter”) attached hereto as Exhibit A (the “Expansion Preparation”); 

 
 WHEREAS, pursuant to the Waiver Request Letter, the Borrower has requested
that the Lenders (i) consent to a modification to the EPC Contract and a waiver of certain provisions of the Credit Agreement to extend the time period for the procurement of insurance and (ii) waive certain provisions of the Credit Agreement to
permit the Expansion Preparation; 
  
 NOW THEREFORE, in
consideration of the mutual agreements herein contained and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound hereby, agree as follows: 

 
 Section 1. Definitions. Capitalized terms (including those used in
the preamble and the recitals above) not otherwise defined herein shall have the meanings assigned to such terms in the Credit Agreement and the principles of interpretation set forth therein shall apply herein. 
  
 Section 2. Consent. The Agent, acting with the consent of the Majority
Lenders, hereby consents to (a) the Borrower entering into a modification of paragraph 1B of Attachment O to the EPC Contract and (b) a waiver of compliance with the provisions of Schedule 8.05 of the Credit Agreement, solely to the extent such
modification and waiver extend 

 
the date by which the Borrower and the EPC Contractor are required to procure the insurance set forth therein from Notice to Proceed to a date which is no
more than 60 days following issuance of Notice to Proceed. 
  
 Section 3. Waiver. The Agent, acting with the consent of the Majority Lenders, hereby waives compliance with Sections 7.11 and 8.17 of the Credit Agreement solely to the extent necessary to permit the Borrower to conduct the
Expansion Preparation as expressly contemplated by the Waiver Request Letter and all activities reasonably incidental thereto, provided that (i) all costs and expenses incurred in connection with such Expansion Preparation and reasonably
incidental activities shall be funded by third parties and shall not be paid out of the Equity Contribution Amount or proceeds of the Loans and (ii) other than as provided in Section 2 hereof, nothing herein shall be construed as a consent to or a
waiver of the Lenders’ or Agent’s rights pursuant to Sections 8.20 or 8.21 of the Credit Agreement. 
  
 Section 4. Effectiveness. This Consent and Waiver shall become effective upon receipt by the Agent of the counterparts of this Consent and Waiver
duly executed and delivered by each of the Borrower, the Agent and the Collateral Agent. 
  
 Section 5. Miscellaneous. 
  
 (a) Limited Waiver. 
  
 (i)
Except as expressly consented to or waived hereby, all of the representations, warranties, terms, covenants, conditions and other provisions of the Credit Agreement and the other Financing Documents shall remain unchanged and unwaived and shall
continue to be and shall remain in full force and effect in accordance with their respective terms. 
  
 (ii) The consent and waiver set forth herein shall be limited precisely as provided for herein to the provisions expressly consented to or
waived herein and shall not be deemed to be a waiver of any right, power or remedy of any Lender, the Agent or the Collateral Agent under, or a waiver of, consent to or modification of any other term or provision of the Credit Agreement, any other
Financing Document referred to therein or herein or of any transaction or further or future action on the part of the Borrower which would require the consent of the Lenders under the Credit Agreement or any of the other Financing Documents.

  
 (iii) Except as provided in Sections 2 and 3
hereof, nothing contained in this Consent and Waiver shall abrogate, prejudice, diminish or otherwise affect any powers, rights, remedies or obligations of any Person arising before the date of this Consent and Waiver. 
  
 (b) Financing Document. This Consent and Waiver shall be deemed to be
a Financing Document referred to in the Credit Agreement and shall be construed, administered and applied in accordance with the terms and provisions thereof. 
  

(c) Counterparts; Integration; Effectiveness. This Consent and Waiver may be executed in any number of counterparts, all of which taken together
shall constitute one and the same instrument and any parties hereto may execute this Consent and Waiver by signing any such counterpart. 
  

 -2- 

 (d) Costs and Expenses. The Borrower agrees to pay and reimburse the Agent for all its reasonable
costs and out-of-pocket expenses (including, without limitation, the reasonable fees and expenses of counsel to the Agent and the Lenders) incurred in connection with the preparation and delivery of this Consent and Waiver and such other related
documents. 
  
 (e) Governing Law. THIS CONSENT
AND WAIVER AND THE RIGHTS AND OBLIGATIONS OF THE PARTIES HEREUNDER SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK. 
  
 [Signature Pages Follow] 
  

 -3- 

 IN WITNESS WHEREOF, the parties hereto have caused this Consent and Waiver to be duly executed and
delivered as of the day and year first above written. 
  

			
	 SABINE PASS LNG, L.P.,

	       as Borrower

		
	 By:
	 	 Sabine Pass LNG – GP, Inc.,
 its General Partner

		
	 By:
	 	 /s/ Graham McArthur

	 Name:
	 	 Graham McArthur

	 Title:
	 	 Treasurer

	
	 Address for Notices:

	
	 717 Texas Avenue, Suite 3100

	 Houston, TX 77002

	 Attn: Treasurer

			
	 SOCIÉTÉ GÉNÉRALE,

	       as Agent

		
	 By:
	 	 /s/ Robert J. Preminger

	 Name:
	 	 Robert J. Preminger

	 Title:
	 	 Director

	
	 Address for Notices:

	
	 1221 Avenue of the Americas

	 New York, NY 10020

	 Attn: Robert Preminger

			
	 HSBC BANK USA, NATIONAL ASSOCIATION,

	       as Collateral Agent

		
	 By:
	 	 /s/ Deirdra N. Ross

	 Name:
	 	 Deirdra N. Ross

	 Title:
	 	 Assistant Vice President

	
	 Address for Notices:

	
	 HSBC Bank USA, National Association

	 452 Fifth Avenue

	 New York, NY 10018

	 Attn: Corporate Trust

	
	 With a copy to:

	
	 DLA Piper Rudnick Gray Cary US LLP

	 One Liberty Place

	 1650 Market Street, Suite 4900

	 Philadelphia, PA 19103

	 Attn: Peter Tucci, Esq.

 Exhibit A 
 to Consent and Waiver 
  
 Waiver
Request Letter 
  
 (see attached) 

 [CHENIERE LETTERHEAD] 
  
 March 16, 2005 
  
 Société Générale 
 1221 Avenue of the Americas

 New York, NY 10020 
 Attn: Robert Preminger 
  

	Re:	Sabine Pass LNG, L.P. (Sabine) 

   Credit Agreement Dated as of February 25, 2005 
  
 Dear Robert: 
  
 Per our conversation Sabine is requesting the following
amendments to the above referenced credit agreement: 
  
 Section 8.05 -
Insurance: Events of Loss 
  
 Sabine hereby requests that all required
insurance provisions currently required to be in place by the Notice to Proceed date (NTP), as defined in the Bechtel Engineering, Procurement and Construction Agreement, be amended to be in place no later than 60 days from the NTP. NTP is currently
contemplated to be April 4, 2005. Please note that there is no equipment anticipated to be delivered during this 60 day period. The insurance that was required to be in place at closing will remain in full force and effect during this period.

  
 Please be advised that in we are going to have to request modifications to the
insurance requirements stipulated under Schedule 8.05 due to the commercial unfeasibility of some of the required coverages. We plan on using the 60 day extension requested above to solidify the terms of the proposed insurance placement and to gain
the required lender approval. 
  
 Sections 7.11 and 8.17 - Nature of
Business 
  
 Sabine hereby requests that the Nature of Business covenant be
expanded to allow for preliminary planning work to be performed in connection with a contemplated expansion of the Sabine facility. This preliminary planning work will entail: 
  
 Technical and Project Management 
  

	•	 	Overall Project Management 

  

	•	 	Assemble Resource Reports 1, 10, 11, 13 for Environmental Assessment 

  

	•	 	MHI prepares LSTK price for Tanks and dikes 

  

	•	 	Negotiate Site sharing Issues with Bechtel 

  

	•	 	Develop EPC package 

 Environmental 
  

	•	 	FERC Environmental Report (ER) Preparation 

  

	•	 	Preparation of Applicant prepared Environmental Assessment 

  

	 	•	 	Federal Permitting 

  

	 	•	 	USACE Jurisdictional determination 

  

	 	•	 	NOAA Fisheries essential fish habitat (if needed) 

  

	 	•	 	USFWS 

  

	•	 	State and local Permitting 

  

	 	•	 	LDEQ Air permit modification 

  

	 	•	 	LDEQ Construction Storm water NOI Modification 

  

	 	•	 	LDWF T/E Species annual reconsult 

  

	 	•	 	SHPO reconsult 

  

	 	•	 	LDNR Coastal use solicitation of views 

  

	 	•	 	Cameron Parish Building Permit 

  
 Geotechnical 
  

	•	 	Site Geotechnical work 

  

	•	 	Preliminary report for FERC 

  

	•	 	Lab work and Final Report 

  
 All costs associated with these activities will be funded entirely outside of the current project finance structure. 
  
 Sincerely, 
  

			
	 SABINE PASS LNG, L.P.

	
	 By: Sabine Pass LNG-GP, Inc., its General Partner

		
	 By:
	 	 /s/ Graham A. McArthur

	 	 	 Graham A. McArthur

	 	 	 Treasurer

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00084-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00084-of-00352.parquet"}]]